ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
A Nephrology Perspective on Managing Heart Failure
A Nephrology Perspective on Managing Heart Failure
Kidney Week 2022 Kicks off With New Perspectives on Transplantation
Kidney Week 2022 Kicks off With New Perspectives on Transplantation
The First Pig-to-Human Kidney Transplant? Anticipated Highlights from Kidney Week 2022
The First Pig-to-Human Kidney Transplant? Anticipated Highlights from Kidney Week 2022
A Look Ahead at ASN's 2022 Kidney Week: Combatting Future Pandemics
A Look Ahead at ASN's 2022 Kidney Week: Combatting Future Pandemics
Me2/ & Classical Music in Mental Health: Expert Insights from the Psych Congress
Me2/ & Classical Music in Mental Health: Expert Insights from the Psych Congress
Psych Congress 2022: A Look at New Mechanisms of Action in Schizophrenia
Psych Congress 2022: A Look at New Mechanisms of Action in Schizophrenia
Exploring Marijuana Use in Psychopharmacology: A Look Ahead at the Psych Congress
Exploring Marijuana Use in Psychopharmacology: A Look Ahead at the Psych Congress
Exploring Anticipated Highlights & Updates from Psych Congress 2022
Exploring Anticipated Highlights & Updates from Psych Congress 2022
Highlights from the Psych Congress: Uncovering Updates from the DSM-5-TR
Highlights from the Psych Congress: Uncovering Updates from the DSM-5-TR
A Look at LAI Antipsychotics for Bipolar I Disorder: A Preview of the Psych Congress
A Look at LAI Antipsychotics for Bipolar I Disorder: A Preview of the Psych Congress
Reviewing Telehealth Rules & Regulations: An Update from the Psych Congress
Reviewing Telehealth Rules & Regulations: An Update from the Psych Congress
Exploring the Latest on Lipids: Updates on Lp(a) in Preventative Cardiology
Exploring the Latest on Lipids: Updates on Lp(a) in Preventative Cardiology
Updates in the New AHA/ACC/HFSA Heart Failure Guideline
Updates in the New AHA/ACC/HFSA Heart Failure Guideline
Cardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM
Cardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM
A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
